Jury Finds for Novo Nordisk on False Claims Allegations

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Jury Finds for Novo Nordisk on False Claims Allegations Linked to Off-Label Marketing, Kickbacks

Dennis Tosh

November 12, 2025 at 03:43 PM EST

A federal district court jury has cleared a hemophilia medication manufacturer of a whistleblower’s allegations that the company violated the False Claims Act by marketing the drug off-label and by providing illegal kickbacks to physicians and patients to induce the drug’s use (United States v. Novo Nordisk, Inc., No. 3:23-cv-05459-BHS (W.D. Wash.)). Dr. Jamie Siegel worked a... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Jury Finds for Novo Nordisk on False Claims Allegations Linked to Off-Label Marketing, Kickbacks

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT